Drug Interaction Report

Rilpivirine and Nizatidine: Interaction Details

AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature

Rilpivirine

Edurant Edurant® Juluca® (as a combination product containing dolutegravir, rilpivirine)
+

Nizatidine

Axid® Axid® AR
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by
Updated Aug 8, 2026
LinkedIn
Interaction severity
Major
Potentially serious — often needs a change or close monitoring.
How we grade severity & evidence

Severity levels

  • Contraindicated: These should generally not be used together.
  • Major: Potentially serious — often needs a change or close monitoring.
  • Moderate: Can be significant — usually manageable with monitoring.
  • Minor: Usually limited clinical impact.

Evidence grades

  • Established: Well documented — supported by controlled studies or strong clinical data.
  • Probable: Good supporting evidence, though not definitively proven.
  • Suspected: Some evidence suggests this interaction, but it is not well established.
  • Possible: Limited or conflicting evidence; the interaction may occur.
  • Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Of 73 documented Rilpivirine interactions, 65 are rated major — including this one.
Worried about symptoms right now? Contact your pharmacist or prescriber, or call Poison Control at 1-800-222-1222 (US). Call 911 for an emergency.
Onset
rapid
Evidence
theoretical
Severity
Major

What happens

Reduced rilpivirine exposure

Interaction Deep Dive

Use caution, concomitant use of rilpivirine or rilpivirine-containing products with drugs that increase gastric pH, such histamine-2 receptor antagonists, may lead to decreased rilpivirine plasma concentrations. During drug interaction studies, a significant decrease in rilpivirine AUC and Cmax was observed in patients administered famotidine 2 hours prior to rilpivirine1. If coadministered, rilpivirine should be given 4 hours before or 12 hours following histamine-2 receptor antagonist administration 21.

Why it happens (mechanism)

Increased gastric pH

Literature reports

1 report — tap to read

a) In drug interaction studies, the concomitant administration of famotidine and rilpivirine in healthy subjects or in patients with antiretroviral treatment-naive HIV-1 did not result in significant changes in rilpivirine AUC or Cmax when administered at least 12 hours before or 4 hours following rilpivirine. However, a significant decrease in rilpivirine AUC and Cmax was observed in patients receiving famotidine 2 hours prior to rilpivirine administration. Patients received a single-dose of famotidine 40 mg taken 12 hours before, 2 hours before, or 4 hours after rilpivirine 150 mg. When famotidine was administered 12 hours before, 2 hours before, or 4 hours following rilpivirine administration the mean ratio (rilpivirine plus famotidine/rilpivirine alone) estimate for rilpivirine was 0.91 (90% CI, 0.78 to 1.07), 0.24 (90% CI, 0.2 to 0.28), and 1.13 (90% CI, 1.01 to 1.27), respectively, for AUC. Similarly, the ratio was 0.99 (90% CI, 0.84 to 1.16), 0.15 (90% CI, 0.12 to 0.19), and 1.21 (90% CI, 1.06 to 1.39), respectively, for Cmax. The mean ratio for Cmin was not available 1.

Common questions

Can I take Rilpivirine and Nizatidine together?

Reduced rilpivirine exposure Always confirm with your pharmacist or prescriber before making any change.

How serious is the Rilpivirine and Nizatidine interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How quickly could this interaction happen?

The documented onset is "rapid". Effects can appear quickly, often within about 24 hours of combining the drugs.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.

Questions for your pharmacist

  • Does my dose of Rilpivirine or Nizatidine need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there a safer alternative to one of these medications for me?

References (2)

  1. Product Information: EDURANT(R) oral tablets, rilpivirine oral tablets. Janssen Therapeutics (per FDA), Horsham, Pa, 2024. DailyMed
  2. Product Information: JULUCA oral tablets, dolutegravir rilpivirine oral tablets. ViiV Healthcare (per FDA), Research Triangle Park, NC, 2022. DailyMed
Was this write-up helpful?
Beyond drug–drug

These medications also interact with supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

major · moderate · minor — check everything you take with our drug–supplement interaction checker.

Check another combination

Our instant two-drug interaction checker is almost here.

Coming soon

The instant two-drug checker is on its way.

In the meantime, browse the directory below to look up any drug and see its documented interactions.

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.